VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price traded down 11.1% during trading on Friday . The stock traded as low as C$0.08 and last traded at C$0.08. 470,001 shares changed hands during mid-day trading, an increase of 330% from the average session volume of 109,238 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Trading Down 11.1 %
The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56. The firm has a market cap of C$12.98 million, a PE ratio of -2.47 and a beta of 0.39. The company’s 50-day moving average is C$0.10 and its 200 day moving average is C$0.14.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Airline Stocks – Top Airline Stocks to Buy Now
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Want to Profit on the Downtrend? Downtrends, Explained.
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
